HK1100359A1 - Malignant tumor inhibitor containing des a fibrin - Google Patents

Malignant tumor inhibitor containing des a fibrin

Info

Publication number
HK1100359A1
HK1100359A1 HK07108557.1A HK07108557A HK1100359A1 HK 1100359 A1 HK1100359 A1 HK 1100359A1 HK 07108557 A HK07108557 A HK 07108557A HK 1100359 A1 HK1100359 A1 HK 1100359A1
Authority
HK
Hong Kong
Prior art keywords
fibrin
malignant tumor
inhibitor containing
tumor inhibitor
containing des
Prior art date
Application number
HK07108557.1A
Other languages
English (en)
Inventor
Hirobumi Senga
Caixia Li
Yongling Wan
Lishui Chang
Original Assignee
Tobishi Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tobishi Pharmaceutical Co filed Critical Tobishi Pharmaceutical Co
Publication of HK1100359A1 publication Critical patent/HK1100359A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK07108557.1A 2004-06-24 2007-08-06 Malignant tumor inhibitor containing des a fibrin HK1100359A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004213635 2004-06-24
PCT/JP2005/012174 WO2006001523A1 (fr) 2004-06-24 2005-06-24 INHIBITEUR DE TUMEUR MALIGNE CONTENANT DE LA FIBRINE Des A

Publications (1)

Publication Number Publication Date
HK1100359A1 true HK1100359A1 (en) 2007-09-21

Family

ID=35781928

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07108557.1A HK1100359A1 (en) 2004-06-24 2007-08-06 Malignant tumor inhibitor containing des a fibrin
HK07110412.2A HK1105091A1 (en) 2004-06-24 2007-09-25 Malignant tumor inhibitor containing des a fibrin

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK07110412.2A HK1105091A1 (en) 2004-06-24 2007-09-25 Malignant tumor inhibitor containing des a fibrin

Country Status (10)

Country Link
US (2) US20060088519A1 (fr)
EP (1) EP1762242B1 (fr)
JP (1) JP4716994B2 (fr)
KR (1) KR101032249B1 (fr)
CN (1) CN1972706B (fr)
AU (1) AU2005257508A1 (fr)
CA (1) CA2566991A1 (fr)
HK (2) HK1100359A1 (fr)
RU (1) RU2358754C2 (fr)
WO (1) WO2006001523A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101896193B (zh) * 2007-12-14 2013-11-20 东菱药品工业株式会社 减轻抗癌药副作用的药剂
AU2009240790C1 (en) * 2008-04-24 2015-04-16 The Australian National University Methods for radiolabelling synthetic polymers
US20210128699A1 (en) * 2017-01-13 2021-05-06 Tobishi Pharmaceutical Co., Ltd. Neutrophil activation regulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE447579B (sv) * 1985-04-01 1986-11-24 Biopool Ab Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar
JP4116683B2 (ja) 1997-02-28 2008-07-09 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 徐放性局所送達製剤
US20020131935A1 (en) * 1998-04-10 2002-09-19 Fisher Darrell R. Fibrin carrier compound for treatment of disease
US6610043B1 (en) * 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
CN1176719C (zh) * 2001-01-05 2004-11-24 江苏安格药业有限公司 降纤酶在制备体内止血药中的应用
AUPR920301A0 (en) 2001-11-30 2001-12-20 Polychip Pharmaceuticals Pty Ltd Neurologically-active compounds
CN1432406A (zh) * 2002-12-20 2003-07-30 周宇 蛇毒蛋白水解酶在制药中的应用

Also Published As

Publication number Publication date
EP1762242B1 (fr) 2012-07-11
AU2005257508A1 (en) 2006-01-05
US8481047B2 (en) 2013-07-09
CA2566991A1 (fr) 2006-01-05
US20060088519A1 (en) 2006-04-27
RU2358754C2 (ru) 2009-06-20
CN1972706B (zh) 2012-03-21
JPWO2006001523A1 (ja) 2008-04-17
KR20070026846A (ko) 2007-03-08
CN1972706A (zh) 2007-05-30
EP1762242A1 (fr) 2007-03-14
HK1105091A1 (en) 2008-02-01
KR101032249B1 (ko) 2011-05-02
JP4716994B2 (ja) 2011-07-06
US20090018062A1 (en) 2009-01-15
RU2006145902A (ru) 2008-08-10
EP1762242A4 (fr) 2009-09-30
WO2006001523A1 (fr) 2006-01-05

Similar Documents

Publication Publication Date Title
IL179398A0 (en) Dpp-ib inhibitors
EP1750696B1 (fr) Inhibiteurs de protéase rétrovirale repoussant leur résistance
AU2003294828A8 (en) Specific markers for pancreatic cancer
EP1732891A4 (fr) Inhibiteurs de la protease retrovirale inhibant la resistance
EP1663281A4 (fr) Inhibiteurs de protease poly-pegylee
EP1499336A4 (fr) Inhibiteurs de protease
EP1660436A4 (fr) Inhibiteurs de la cathepsine
GB0219961D0 (en) Oxytocin inhibitors
EP1799244A4 (fr) Inhibiteurs de la furine
GB0421838D0 (en) Cancer markers
EP1663279A4 (fr) Inhibiteurs de protease modifies
EP1704142A4 (fr) Inhibiteurs de la protease
HRP20050162A2 (en) ?-lactamase inhibitor prodrug
HK1105091A1 (en) Malignant tumor inhibitor containing des a fibrin
AU2003299901A8 (en) Thrombin inhibitors
GB0421355D0 (en) Inhibitors
AU2003269984A8 (en) Protease inhibitors
EP1609479A4 (fr) Inhibiteur d'oncogenese
HK1106142A1 (en) Malignant tumor local infiltration inhibitor containing batroxobin
GB0421356D0 (en) Inhibitors
AU2003263738A8 (en) Protease inhibitors
EP1674100A4 (fr) Inhibiteur d'angiogenese
GB0318913D0 (en) Apoptosis inhibitors
EP1905445A4 (fr) Inhibiteur de croissance tumorale
IL181397A0 (en) Information selection

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210624